Another biotech CEO to leave Rudnic departs as head of MiddleBrook as part of a $100M cash infusion \ Featured Jobs For the second time in two weeks, a giant of Marylands biotech industry has announced plans to step down.More News Last week it was CEO David M.
Mott...
With $100 Million Influx, MiddleBrook CEO Is Out Edward M.Rudnic, MiddleBrook Pharmaceuticals's chief executive, plans to leave the company he founded in exchange for an outside investment of $100 million.
MiddleBrook has been openly searching for a buyer over the past year.
In the...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) Strategic Review Results in $100MM Investment by Equity Group Investments;Experienced Commercial Executive Management Team Appointed;Preparing for Potential MOXATAG Launch in the First Half of 2009 GERMANTOWN, Md., July 1 /PRNewswire...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM) GERMANTOWN, Md., July 1 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc.(Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of...
Shares of MiddleBrook Pharmaceuticals Tumble On Resignation Of President, CEO (RTTNews) - Shares of pharmaceutical company MiddleBrook Pharmaceuticals, Inc.(MBRK | Quote | Chart | News | PowerRating) plunged Wednesday morning after the company announced the resignation of the company's President and CEO Edward...
MiddleBrook Sinks as Buyout Hopes Fade MiddleBrook Pharmaceuticals MBRK couldn't find a buyer.The Germantown, Md.-based drugmaker said Wednesday that an outside investment group will pump $100 million into the company to fund the commercial launch of its recently approved...
Middlebrook Pharma gets $100M investment GERMANTOWN, Md.- Drug maker MiddleBrook Pharmaceuticals Inc.
said President and Chief Executive Edward M.
Rudnic will step down under terms of Equity Group Investments LLC's $100 million investment in the company.
Shares fell $1.56,...
Middlebrook Pharma gets $100M investment Drug maker MiddleBrook Pharmaceuticals Inc.said President and Chief Executive Edward M.
Rudnic will step down under terms of Equity Group Investments LLC's $100 million investment in the company.
Shares fell $1.56, or 51 percent, to ...
Middlebrook Pharma gets $100M investment Shares fell $1.56, or 51 percent, to $1.51 in premarket trading, having closed Tuesday's regular session at $3.07.Middlebrook is selling 30.3 million common shares at $3.30 each to Equity Group and a five-year warrant to buy 12.1 million...
Middlebrook Pharma gets $100M investment GERMANTOWN, Md.(AP) -- Drug maker MiddleBrook Pharmaceuticals Inc.
said President and Chief Executive Edward M.
Rudnic will step down under terms of Equity Group Investments LLC's $100 million investment in the company.
Shares fell ...
MiddleBrook Pharma plunges 50% after $100M investment announcement MiddleBrook Pharmaceuticals Inc.(Nasdaq:MBRK) tanked 50% in pre-market trading on Wednesday after the company announced late Tuesday it had made an agreement with private investment firm Equity Group Investments for $100 million equity...
Q&a: Disease's Cause, Cures What is it?Lyme disease is caused by the bacterium Borrelia burgdorferi?
How do you get it?
It is transmitted to humans by the bite of infected black-legged ticks - in our area, the deer tick - that can be carried on rodents, deer or...
FDA MedWatch - March 2008 Safety-Related Labeling Changes Posted -The March 2008 posting includes 50 drug products with safety labeling changes to the following sections: BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, and PATIENT PACKAGE INSERTS, and MEDICATION ES.The...
Evaluation and Management of the Infected Total Hip and Knee Describe a classification system and discuss the relevant prognostic factors that aid in the management of the infected hip and knee arthroplasty.Discuss the currently available tests that are used in the diagnosis of infected total hip...
